Artelo Biosciences, Inc. (ARTL) vs Clearmind Medicine Inc. (CMND)
A side-by-side comparison of Artelo Biosciences, Inc. and Clearmind Medicine Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTL
Artelo Biosciences, Inc.
$3.65HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
CMND
Clearmind Medicine Inc.
$5.70HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — ARTL vs CMND
growth of $100 · dividends reinvested · last 4yARTL -97.8% (-61.3%/yr)CMND -100.0% (-94.3%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
ARTL CMND
ARTL vs CMND: by the numbers
- •ARTL is the larger company ($1M vs $1M market cap).
Metrics side by side
Valuation
| Metric | ARTL | CMND |
|---|---|---|
| P/B ratio | 0.28 | 0.08 |
Profitability
| Metric | ARTL | CMND |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -253.57% | -57.87% |
| ROIC | -219.36% | -60.41% |
Growth (annualized)
| Metric | ARTL | CMND |
|---|---|---|
| Total return CAGR (5Y) | -64.27% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.